|
MOSPD2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.760400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.487400E-01 |
| Normal-vs-Stage2 |
4.512400E-01 |
| Normal-vs-Stage3 |
7.137700E-02 |
| Normal-vs-Stage4 |
9.201300E-03 |
| Stage1-vs-Stage2 |
7.030000E-01 |
| Stage1-vs-Stage3 |
8.762700E-03 |
| Stage1-vs-Stage4 |
1.544470E-03 |
| Stage2-vs-Stage3 |
4.604000E-02 |
| Stage2-vs-Stage4 |
1.624430E-02 |
| Stage3-vs-Stage4 |
4.686000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.159400E-01 |
| Normal-vs-AfricanAmerican |
4.47970000000408E-05 |
| Normal-vs-Asian |
2.037800E-01 |
| Caucasian-vs-AfricanAmerican |
1.72984999999848E-05 |
| Caucasian-vs-Asian |
1.228400E-01 |
| AfricanAmerican-vs-Asian |
5.757000E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.545200E-01 |
| Normal-vs-Female |
4.066200E-01 |
| Male-vs-Female |
5.385800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.580000E-01 |
| Normal-vs-Age(41-60Yrs) |
8.498200E-01 |
| Normal-vs-Age(61-80Yrs) |
4.327600E-01 |
| Normal-vs-Age(81-100Yrs) |
8.598000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.290600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.757000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.236600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.008000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.800230E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.334200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.277900E-02 |
| Normal-vs-Grade 2 |
2.672000E-01 |
| Normal-vs-Grade 3 |
1.517560E-01 |
| Normal-vs-Grade 4 |
3.576800E-03 |
| Grade 1-vs-Grade 2 |
4.430800E-01 |
| Grade 1-vs-Grade 3 |
5.475800E-02 |
| Grade 1-vs-Grade 4 |
6.302100E-03 |
| Grade 2-vs-Grade 3 |
8.095000E-03 |
| Grade 2-vs-Grade 4 |
4.178400E-04 |
| Grade 3-vs-Grade 4 |
5.195900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.585800E-02 |
| Normal-vs-ccB subtype |
3.610000E-01 |
| ccA subtype-vs-ccB subtype |
1.921030E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.011400E-01 |
| Normal-vs-N1 |
1.388850E-01 |
| N0-vs-N1 |
1.011010E-01 |
|
|
